Elisabeth Pedersen is a Dermatology physician affiliated with University of Michigan. OpenAlex indexes 83 publications with 2,174 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
33.9%Corticosteroid20%Triamcinolone Acetonide100%Part D≥11 patientsInterleukin-4 Receptor alpha Antagonist13.9%Dupixent Pen100%Part D<11 patientsSensory organs
28.7%Corticosteroid28.7%Clobetasol Propionate100%Part D≥17 patientsNervous system
13.9%Gabapentinoids13.9%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2014–2016 per NIH RePORTER. The latest:
- Investigating LGR5/Wnt signaling in Ewing sarcoma pathogenesis
University of Michigan at Ann Arbor
FY2016$34,015F30CA183276 - Investigating LGR5/Wnt signaling in Ewing sarcoma pathogenesis
University of Michigan at Ann Arbor
FY2015$33,559F30CA183276 - Investigating LGR5/Wnt signaling in Ewing sarcoma pathogenesis
University of Michigan at Ann Arbor
FY2014$33,115F30CA183276
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation
Science Translational Medicine
2025 - Epidemiological outcomes and policy implementation in the Nordic countries during the COVID-19 pandemic
Archives of Public Health
2025 - Cross-disease comparison of dermatomyositis and lupus skin identifies inflammatory monocytes and JAK-1 signaling as drivers of vasculopathy in dermatomyositis
bioRxiv (Cold Spring Harbor Laboratory)
2025 - Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
Frontiers in Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”